Scott Boyer

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Computational Toxicology Services LLC specializes in toxicity screening of pharmaceuticals. The private company is based in Rockville, MD.

Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden.

Part of Klaria Pharma Holding AB, Klaria Pharmaceuticals AB develops pharmaceuticals. The company is based in Stockholms, Sweden. The CEO of the Swedish company is Scott Boyer.

Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals.

Nutrinovate AB develops, produces and sells health beauty and dietary supplement products. The company was founded by Scott Boyer and Magnus Nilsson Vall in 2015 and is headquartered in Taby, Sweden.

Chemotargets SL is a Spanish company that offers predictive analytics and translational safety solutions for pharmaceutical, biotech, and research institutions. The private company helps to find repurposing options for drugs already approved for certain indications to novel therapeutic uses. The company's innovative data science solution, CLARITY, is used by big and small pharma companies, as well as the FDA for Drug Evaluation and Research. The team at Chemotargets aims to help the biopharma industry speed up the process of bringing new medicines to market while improving safety concerns. The CEO of the company is Scott Boyer.